The role of radiation therapy in the control of locoregional and metastatic cancer

Journal of Surgical Oncology

Volumn 103, Issue 6, 2011, Pages 627-638

  Stea, Baldassarre ^a   Hazard, Lisa J ^a   Gonzalez, Victor J ^a   Hamilton, Russell ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

locoregional; metastatic; radiation; therapy

Indexed keywords

ARTICLE; BREAST CANCER; CANCER THERAPY; CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS CANCER; INTENSITY MODULATED RADIATION THERAPY; LOCAL THERAPY; METASTASIS; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOTHERAPY; RECTUM CANCER; REGIONAL THERAPY; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; STOMACH CANCER; SURVIVAL; TUMOR RECURRENCE;

BRACHYTHERAPY; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; RADIOSURGERY; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; THERAPY, COMPUTER-ASSISTED;

EID: 79953891398     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21837     Document Type: Article

References (67)

1. Brahme A, Roos J-E, Lax I,: Solution of an integral equation encountered in radiation therapy. Phys Med Biol 1982; 27: 1221-1229. (Pubitemid 12034105)
2. Bortfelt T,: IMRT: A review and preview. Phys Med Biol 2006; 51: R363-R379.
3. McNeer G, Vandenberg H, Donn FY, et al.: A critical evaluation of subtotal gastrectomy for the cure of cancer of the stomach. Ann Surg 1957; 134: 2-7.
4. Horn R,: Carcinoma of the stomach: Autopsy findings in untreated cases. Gastroenterology 1955; 29: 515-525.
5. Thomson F, Robins RE,: Local recurrence following subtotal resection for gastric carcinoma. Surg Gynecol Obstet 1952; 95: 341-344.
6. Stout A,: Pathology of carcinoma of the stomach. Arch Surg 1943; 46: 807-822.
7. Hallissey M, Dunn JA, Ward LC, et al.: The second British Stomach Cancer Group Trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: Five-year follow-up. Lancet 1994; 343: 1309-1312.
8. Allum W, Hallissey MT, Ward LC, et al.: A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: Interim report. British Stomach Cancer Group. Br J Cancer 1989; 60: 739-744. (Pubitemid 19275741)
9. Zhang Z, Gu XZ, Yin WB, et al.: Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocaricnoma of gastric cardia (AGC)-Report on 370 patients. Int J Radiat Oncol Biol Phys 1998; 42: 929-934. (Pubitemid 29004131)
10. MacDonald J, Smalley SR, Beneditti J, et al.: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-730.
11. Cunningham D, Allum WH, Stenning SP, et al.: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
12. Klinkenbijl J, Jeekel J, Sahmoud T, et al.: Adjuvant radiotherpay and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Ann Surg 1999; 230: 776-782.
13. Neoptolemos J, Stocken DD, Hemult F,: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350: 1200-1210. (Pubitemid 38339364)
14. Regine W, Winter KA, Abrams R, et al.: A Phase III Intergropu Trial (RTOG 97-04) of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys 2006; 66: S23-S24.
15. Oettle H, Post S, Neuhaus P, et al.: Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA 2007; 297: 267-277. (Pubitemid 46143304)
16. Roldan G, Gunderson LL, Nagorney DM, et al.: External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer 1988; 61: 1110-1116. (Pubitemid 18078599)
17. Mohiuddin M, Cantor RJ, Bierman W, et al.: Combined modality treatment of localized unresectable adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1988; 14: 79-84. (Pubitemid 18059133)
18. Garton G, Gunderson LL, Nagorney DM, et al.: High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 1993; 27: 1153-1157. (Pubitemid 23361598)
19. Mohiuddin M, Regine WF, Stevens J, et al.: Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas. J Clin Oncol 1995; 13: 2764-2768.
20. Regine WF, Winter KA, Abrams RA, et al.: Fluorouracil vs. gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial. JAMA 2008; 299: 1019-1026. (Pubitemid 351347058)
21. Wayne J, Abdalla EK, Wolff RA, et al.: Localized adenocarcinoma of the pancreas: The rationale for preoperative chemoradiation. The Oncologist 2002; 7: 34-45. (Pubitemid 34151106)
22. Francis R, James LA, Jeffrey EL, et al.: Preoperative and postoperative chemoradiation strategies in patients in patients treatment with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997; 15: 928-937.
23. Magnin V, Moutardier V, Giovannini MH, et al.: Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer. Int J Radiat Oncol Biol Phys 2003; 55: 1300-1304. (Pubitemid 36338297)
24. Pahlman L, Glimelius B, Cedermark B, et al.: Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336: 980-987. (Pubitemid 27152783)
25. Fisher B, Wolmark N, Rockette H, et al.: Postoperative adjuvant chemotherapy or RT for rectal cancer: Results from NSABP protocol R-01. J Natl Cancer Inst 1988; 80: 21-29. (Pubitemid 18076565)
26. Holyoke ED, Mittelman A, Panahon A, et al.: Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 1985; 312: 1465-1472.
27. Ridgway PF, Darzi AW,: The role of total mesorectal excision in the management of rectal cancer. Cancer Control 2003; 10: 205-211. (Pubitemid 36665842)
28. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646.
29. Sebag-Montefiore D, Stephens RJ, Steele R, et al.: Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet 2009; 373: 811-820.
30. Marijnen CA, VanGijn W, Nagtegaal I, et al.: The TME trial after a median follow-up of 11 years. Int J Radiat Oncol Biol Phys 2010; 78: S1.
31. Sauer R, Becker H, Hohenberger W, et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
32. Herskovic A, Martz K, al-Sarraf M, et al.: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-1598.
33. Urschel JD,: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185: 538-543. (Pubitemid 36627845)
34. Tepper J, Krasna MJ, Niedzwiecki D, et al.: Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008; 26: 1086-1092.
35. Urba S,: Combined-modality treatment of esophageal cancer. Oncology (Williston Park) 1997; 11: 63-67. (Pubitemid 127521320)
36. Bosset JF, Gignoux M, Triboulet JP, et al.: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161-167. (Pubitemid 27306287)
37. Walsh T, Noonan N, Hollywood D, et al.: A comparison of multimodality therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-467. (Pubitemid 26269945)
38. Burmeister BH, Smithers BM, Gebski V, et al.: Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial. Lancet Oncol 2005; 6: 659-668. (Pubitemid 41222756)
39. Moertel C, Childs DS, O'Fallon JR, et al.: Combined 5-fluorouracil and RT as a surgical adjuvant for poor prognosis gastric carcinoma. J Clin Oncol 1984; 2: 1249-1254. (Pubitemid 15202699)
40. Kalser M, Ellengerg S,: Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120: 899-903. (Pubitemid 15040883)
41. Clarke M, Collins R, Darby S, et al.: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005; 366: 2087-2106. (Pubitemid 41797643)
42. Bartelink H, Horiot JC, Poortmans PM, et al.: Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC22881-1088 trial. J Clin Oncol 2007; 25: 3259-3265. (Pubitemid 47325610)
43. Romestaing P, Lehingue Y, Carrie C, et al.: Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997; 15: 963-968. (Pubitemid 27106278)
44. Antonini N, Jones H, Horiot JC, et al.: Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol 2007; 82: 265-271. (Pubitemid 46341468)
45. Bentzen SM, Agrawal RK, Aird EG, et al.: The UK standardisation of breast radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet 2008; 371: 1098-1107.
46. Whelan TJ, Pignol JP, Levine MN, et al.: Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010; 362: 513-520.
47. Liljegren G, Holmberg L, Bergh J, et al.: 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 1999; 17: 2326-2333. (Pubitemid 29368230)
48. Fisher B, Anderson S, Bryant J, et al.: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-1241. (Pubitemid 35176242)
49. Vicini FA, Kestin L, Chen P, et al.: Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 2003; 95: 1205-1210.
50. Chen PY, Vicini FA, Benitez P, et al.: Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: A method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer 2006; 106: 991-999.
51. Smith BD, Arthur DW, Buchholz TA, et al.: Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg 2009; 209: 269-277.
52. Vaidya JS, Joseph DJ, Tobias JS, et al.: Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): An international, prospective, randomised, non-inferiority phase 3 trial. Lancet 2010; 376: 91-102.
53. Ragaz J, Olivotto IA, Spinelli JJ, et al.: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005; 97: 116-126. (Pubitemid 40277091)
54. Overgaard M, Hansen PS, Overgaard J, et al.: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997; 337: 949-955. (Pubitemid 27425950)
55. Overgaard M, Jensen MB, Overgaard J, et al.: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999; 353: 1641-1648. (Pubitemid 29224519)
56. Taghian AG, Jeong JH, Mamounas EP, et al.: Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: Results from five national surgical adjuvant breast and bowel project randomized clinical trials. J Clin Oncol 2006; 24: 3927-3932. (Pubitemid 46655604)
57. Floyd SR, Buchholz TA, Haffty BG, et al.: Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger. Int J Radiat Oncol Biol Phys 2006; 66: 358-364. (Pubitemid 44332731)
58. Strom EA, Woodward WA, Katz A, et al.: Clinical investigation: Regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 2005; 63: 1508-1513. (Pubitemid 41628050)
59. Recht A, Gray R, Davidson NE, et al.: Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999; 17: 1689-1700. (Pubitemid 29269237)
60. Chen RC, Lin NU, Golshan M, et al.: Internal mammary nodes in breast cancer: Diagnosis and implications for patient management-A systematic review. J Clin Oncol 2008; 26: 4981-4989.
61. Leksell L,: The stereotactic method and radiosurgery of the brain. Acta Chir Scand 1951; 102: 316-319.
62. Winston KR, Lutz W,: Linear accelerator as neurosurgical tool for stereotactic radiosurgery. Neurosurgery 1988; 22: 454-464. (Pubitemid 18095946)
63. Shaw E, Scott C, Souhami L, et al.: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000; 47: 291-298. (Pubitemid 30236367)
64. Andrews DW, Scott CB, Sperduto PW, et al.: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomized trial. Lancet 2004; 363: 1665-1672. (Pubitemid 38670323)
65. Kocher M, Soffietti R, Abacioglu U, et al.: Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: Results of the EORTC 22952-26001 Study. J Clin Oncol 2010; 29: 134-141.
66. Timmerman R, Paulus R, Galvin J, et al.: Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303: 1070-1076.
67. Sahgal A, Larson DA, Chang EL,: Stereotactic body radiosurgery for spinal metastases: A critical review. Inter J Radiat Oncol Biol Phys 2008; 71: 652-665. (Pubitemid 351749532)